N2OFF regains compliance with Nasdaq minimum bid price requirement

NEVE YARAK, ISRAEL - N2OFF, Inc. (NASDAQ:NITO), a cleantech company focused on solar energy assets with a market capitalization of $4.44 million, announced Wednesday it has regained compliance with Nasdaq’s minimum bid price requirement.

According to a notification letter from Nasdaq’s Listing Qualifications Department, N2OFF’s American Depositary Shares (ADSs) maintained a closing bid price of $1.00 or greater for 10 consecutive business days from September 22 to October 3, 2025. The stock has shown significant volatility, posting a 21.67% gain in the past week despite a 36.6% decline over the previous six months, according to InvestingPro data. This resolves the compliance issue that began when the company was notified on March 28, 2025, that it had fallen below the minimum bid price requirement.

The company had been out of compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00. Nasdaq has confirmed the matter is now closed.

N2OFF primarily invests in European Union-based solar assets using the Ready to Build (RTB) business model. The company currently serves as the lead investor in four solar projects across three EU countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.

Additionally, N2OFF controls approximately 98% of Save Foods Ltd., an Israeli company that develops post-harvest treatments for fruits and vegetables.

This announcement is based on information provided in a company press release.

In other recent news, N2OFF, Inc. has made significant strides in its business operations. The company announced the completion of the second installment of a $2.7 million investment for developing two Battery Energy Storage Systems in Sicily, Italy, with a combined capacity of approximately 196 MWp. Additionally, N2OFF has entered into a $372,000 loan agreement with MitoCareX Bio Ltd. and L.I.A. Pure Capital Ltd., with the loan guaranteed by L.I.A. Pure Capital Ltd. In a notable development, shareholders of N2OFF approved the acquisition of SciSparc’s majority-owned subsidiary, MitoCareX Bio Ltd., marking a crucial milestone in making MitoCareX a wholly owned subsidiary.

Furthermore, N2OFF has reported advancements in several renewable energy projects across Europe through its partnership with Solterra Renewable Energy Ltd. The company also announced a one-for-35 reverse stock split of its common stock, which took effect on September 22, 2025. These developments reflect N2OFF’s ongoing efforts to expand its renewable energy initiatives and strengthen its financial structure.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.